Skip to main content

Year: 2026

Global Crossing Airlines Reports Fourth Quarter & Full Year 2025 Financial Results

Reports More Than Quadrupled EBITDA on Record Asset Utilization and First Ever Annual Positive Operating Income and Record Operating Cash Flow MIAMI, March 04, 2026 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the “Company” or “GlobalX”), The Nation’s Fastest Growing Charter Airline®, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2025. Except as otherwise disclosed, all figures are presented in United States dollars and prepared in accordance with U.S. GAAP.Financial and Operational Summary  Q4 2025 Q4 2024 % ChangeRevenue: $60.3M $59.9M 1%Operating Income: $1.5M $3.5M (57%)Net Loss: $1.9M $0.6M N/AEBITDAR1: $19.0M $19.4M (2%)EBITDA1: $5.3M $5.2M 2%Net Aircraft Available: 14.3 15.6 (8%)Total...

Continue reading

Global Water Resources Reports Full Year 2025 Results

PHOENIX, March 04, 2026 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the full year ended December 31, 2025. Unless otherwise noted, all comparisons are to the corresponding period in the prior year. The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Financial HighlightsTotal revenue increased 5.8% year-over-year (“YoY”) to $55.8 million. The increase was primarily due to the recent acquisition of seven water systems from Tucson Water, organic connection growth, increased consumption and higher rates. Net income decreased to $3.0 million or $0.11 per share, a decrease of $2.8 million or 48.9% YoY. The decrease primarily reflects the company’s capital improvement...

Continue reading

MISTRAS Announces Fourth Quarter and Full Year 2025 Results

Solid Quarterly Revenue Growth of 5.1%,with an Expansion in Gross Profit Margin of 190 Basis Points,Generating Net Income of $3.9 million and Earnings Per Diluted Share of $0.12, Achieving Record Fourth Quarter Adjusted EBITDA of $24.8 million PRINCETON JUNCTION, N.J., March 04, 2026 (GLOBE NEWSWIRE) — MISTRAS Group, Inc. (NYSE: MG), a global leader in technology-enabled industrial asset integrity and testing solutions, reported financial results for its fourth quarter and twelve months ended December 31, 2025. Fourth Quarter 2025 Key Figures*Revenue of $181.5 million, an increase of 5.1%, with growth across all segments Gross profit of $51.5 million, reflecting a gross margin of 28.4%, an expansion of 190 basis points Net income of $3.9 million and Earnings Per Diluted Share of $0.12 Record Adjusted EBITDA of $24.8 million,...

Continue reading

Aware Reports Fourth Quarter and Full Year 2025 Financial Results

BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global leader in biometric identity and authentication solutions, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 and Recent Operational HighlightsExpanded federal and commercial engagement with the deployment of Aware’s first mobile biometric solution within a U.S. federal agency and continued growth across international government programs.Expanded partner relationships through integrations with digital workflow providers and a partnership with a biometric hardware vendor. These efforts are intended to support Aware’s broader go-to-market strategy over time.Strengthened Aware’s industry leadership and core biometric technology through multiple independent validations,...

Continue reading

Record Performance Fuels Long-Term Value Creation for Linamar

GUELPH, Ontario, March 04, 2026 (GLOBE NEWSWIRE) — Linamar Corporation (TSX: LNR) Continued Strong Free Cash Flow and Liquidity$937.2 million of Free Cash Flow1 generated in 2025, up $148.9 million from the prior year due to careful cash management, resulting in the 13th consecutive year of positive Free Cash Flow and the second highest in Linamar’s history; and Liquidity1 is strong at $2.1 billion, up $216.9 million or 11.8% from Q4 2024.Outstanding Earnings Performance from Our Diversified StrategyRecord Normalized Net Earnings1 achieved for second consecutive year at $622.1 million despite moderately lower sales at $10.2 billion; Normalized Earnings per Share1 has increased 25.3% to $2.28 for the quarter and 5.6% to an annual record of $10.36 for 2025; and 2025 marks 13 out of 16 years of earnings growth at Linamar; consistent...

Continue reading

SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update

SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling $24.8 million from GSKSCYNEXIS announced dosing of the first patient using the intravenous (IV) formulation of SCY-247 in a Phase 1 study and plans to report topline data in the second half of 2026  Responding to patients’ need for alternatives to existing anti-fungal therapies, SCYNEXIS plans to initiate an expanded access program for SCY-247 in the first half of 2026SCYNEXIS ended Q4 2025 with cash, cash equivalents and investments of $56.3 million, resulting in a cash runway of more than two yearsJERSEY CITY, N.J., March 04, 2026 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the...

Continue reading

COMPX REPORTS FOURTH QUARTER 2025 RESULTS

Dallas, Texas, March 04, 2026 (GLOBE NEWSWIRE) — CompX International Inc. (NYSE American: CIX) announced today net sales of $37.7 million for the fourth quarter of 2025 compared to $38.4 million in the same period of 2024. Operating income was $5.6 million in the fourth quarter of 2025 compared to $4.9 million in the same period of 2024. Net income was $4.7 million, or $.38 per basic and diluted common share, for the fourth quarter of 2025 compared to $4.5 million, or $.37 per basic and diluted common share, in the same period of 2024. Net sales for the year ended December 31, 2025 were $158.3 million compared to $145.9 million in the previous year. Operating income was $22.6 million for the year ended December 31, 2025 compared to $17.0 million in 2024. Net income for the year ended December 31, 2025 was $19.5 million, or $1.58...

Continue reading

Castellum, Inc. Announces 2025 Unaudited Financial Results

Castellum, Inc. Announces 2025 Unaudited Financial ResultsCastellum, Inc. (NYSE-American: CTM), announces certain unaudited highlights of its operating results for its year ended December 31, 2025 – www.castellumus.comVIENNA, Va., March 04, 2026 (GLOBE NEWSWIRE) — Castellum, Inc. (“Castellum” “CTM”, “we” or the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces certain unaudited highlights of its operating results for its year ended December 31, 2025. Revenue for 2025 increased to $52.9 million, representing an $8.1 million (15.2%) increase over $44.8 million in 2024. Operating loss improved to $2.8 million, a $4.4 million year-over-year improvement from an operating loss of $7.2 million in 2024. Net loss to common shareholders...

Continue reading

NN, Inc. Reports Fourth Quarter and Full Year 2025 Results

NN delivers third consecutive year of successful transformation; completes majority of heavy spending NN forecasts fourth year of improvement, and a return to organic net sales growth in 2026 CHARLOTTE, N.C., March 04, 2026 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today reported its financial results for the fourth quarter and full-year ended December 31, 2025. Key results include: Financial HighlightsQ4 2025 net sales of $104.7 million and full-year 2025 net sales $422.2 million Q4 2025 gross margin of 9.2% and full-year 2025 gross margin of 14.1% Q4 2025 adjusted gross margin of approximately 18.8%, up 120 bps and approaching the Company’s five-year target of 20% Q4 2025 operating...

Continue reading

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent HighlightsDelivered $90.5 million in worldwide revenue for the full year of 2025, an 8% increase over the prior year and an increase of 7% on a constant currency basis Achieved worldwide revenue of $22.6 million for the fourth quarter of 2025, a 5% decrease over the same period last year and a decrease of 7% on a constant currency basis Realized gross margin of 78% in the fourth quarter of 2025 and 74% for the full year of 2025 Refinanced existing debt, securing up to $60 million in committed capital under a new 5-year interest-only...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.